Table 1.
Baseline Characteristics of Patients Treated with 125 mg/m2 Albumin-bound Paclitaxel
| Characteristic | 2-Hour Infusion (N=25) | 30-Minute Infusion (N=40) | ||
|---|---|---|---|---|
| No. | % | No. | % | |
| Age, years | ||||
|
| ||||
| Median | 66 | 70 | ||
|
| ||||
| Range | 49 – 83 | 43 – 84 | ||
|
| ||||
| Sex | ||||
|
| ||||
| Female | 14 | 56 | 21 | 53 |
|
| ||||
| Male | 11 | 44 | 19 | 48 |
|
| ||||
| Karnofsky Performance Status | ||||
|
| ||||
| 90% – 100% | 5 | 20 | 10 | 25 |
|
| ||||
| 70% – 80% | 20 | 80 | 30 | 75 |
|
| ||||
| Smoking history, pack-years | ||||
|
| ||||
| Never | 0 | 0 | 2 | 5 |
|
| ||||
| 0–15 | 5 | 20 | 7 | 18 |
|
| ||||
| > 15 | 20 | 80 | 31 | 78 |
|
| ||||
| Histology | ||||
|
| ||||
| Squamous | 7 | 28 | 8 | 20 |
|
| ||||
| Adenocarcinoma | 18 | 72 | 32 | 80 |
|
| ||||
| Baseline neuropathy | ||||
|
| ||||
| Grade 0 | 20 | 80 | 30 | 75 |
|
| ||||
| Grade 1 | 5 | 20 | 10 | 25 |